• SENSEX 76,917.85
    1,225.07 (+1.62%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,814.50 1,878.00(%)
  • Jio Platforms
    1,440.80 1,490.00(%)
  • Bharti Airtel
    2,080.70 2,174.70(%)
  • Reliance Industries
    1,307.00 1,611.20(%)
  • BLS Polymers
    285.25 285.25(%)
  • Solar Industries
    20,860.00 22,630.05(%)
  • Multi Comm. Exc.
    3,537.00 3,537.00(%)
  • Aegis Logistics
    1,253.90 1,528.00(%)
  • SBI
    961.35 933.85(%)
  • HDFC Bank
    725.70 1,017.90(%)
  • Oil India
    451.30 395.75(%)
  • Garden Reach Sh.
    2,235.00 3,338.90(%)
  • Divi's Lab.
    10,035.00 10,035.00(%)
  • M & M Fin. Serv.
    267.15 415.00(%)
  • Sagility
    41.98 35.82(%)
  • SFC Enviro.
    424.85 424.85(%)
  • Mankind Pharma
    2,523.70 2,640.30(%)
  • M & M
    2,910.95 3,840.00(%)
  • Kanohar Elect.
    1,165.90 1,210.00(%)
  • Laurus Labs
    2,252.50 913.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Glaxosmithkline Pharmaceuticals Ltd Pharmaceuticals - Multinational

  • MNC Asc-Glaxo
  • BSE Code : 195.0
  • ISIN : INE159A01016
2,575.10 44 (1.73%)
  • As on 03 Nov 2026 (EOD)

  • Today’s Low

    2,540.40

  • Today’s High

    2,605.90

  • Open

    2,540.40

  • Perv Close

    2,531.40

  • 52W Low

    2,088.10

  • 52W High

    3,120.70

Key Indicators

  • P/E(TTM)

    41.19

  • Mar.Cap (₹Cr.)

    43,623.75

  • Div & Yield %

    2.22

  • Book Value(₹)

    132.30

  • Debt-Equity Ratio

    1.73

  • AGM Date

    03-Nov-2026

  • EPS

    62.48

  • P/E Ratio

    41.19

Financials Ratios

  • Debt-Equity Ratio

    0.01

  • Mar.Cap (₹Cr.)

    43,623.75

  • RONW (%)

    37.32

  • ROCE (%)

    44.97

Score Board

  • Equity (₹ in Cr.)

    169.41

  • BV (₹)

    132.30

  • Sales( ₹ in Cr.)

    3,790.20

  • NP (in Cr.)

    951.37

  • NP Var(%)

    10.0

  • Div%

    570.0

  • CPS (₹)

    60.10

  • EPS (₹)

    56.20

  • Traded Value (₹ in Lakhs)

    43,593.25

  • 52 Week High

    3,120.70

  • 52 Week Low

    2,088.10

  • Price BSE

    2573.0

  • Price NSE

    2,575.00

  • Market Capital( in Cr.)

    43,593.25

  • P/C Ratio

    42.80

  • P/E Ratio

    45.80

  • Price Vs.BV

    56.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 3,790.20 3,723.49 3,407.25 3,216.34 3,217.51 2,920.48
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 3,790.20 3,723.49 3,407.25 3,216.34 3,217.51 2,920.48
Other Income 145.20 147.26 143.17 114.96 1,423.27 217.71
Stock Adjustments -13.50 -51.23 69.64 -67.25 -13.83 26.12
Total Income 3,921.90 3,819.52 3,620.06 3,264.05 4,626.95 3,164.31
EXPENDITURE :            
Raw Materials 1,310.52 1,315.97 1,358.07 1,182.78 1,281.91 1,275.49
Power and Fuel Cost 30.36 30.18 29.64 29.60 27.83 26.08
Employee Cost 607.25 579.70 624.39 594.99 610.23 616.16
Other Manufacturing Expenses 101.49 114.26 113.61 99.05 120.14 110.59
Selling and Administration Expenses 366.21 383.95 374.71 370.30 343.57 242.00
Miscellaneous Expenses 60.68 78.91 239.12 84.32 85.69 287.75
Employee Benefit Expenses 607.25 579.70 624.39 594.99 610.23 616.16
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 2,476.51 2,502.98 2,739.54 2,361.04 2,469.38 2,558.07
Operating Profit 1,445.40 1,316.54 880.52 903.01 2,157.57 606.24
Interest 2.73 1.31 1.80 1.81 1.99 3.53
Gross Profit 1,442.67 1,315.23 878.72 901.20 2,155.58 602.71
Depreciation 66.44 66.79 69.68 65.77 68.19 78.60
Profit Before Tax 1,376.23 1,248.44 809.04 835.43 2,087.39 524.11
Current Tax 354.95 323.18 235.71 246.05 407.36 158.67
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 9.46 6.20 -11.36 -18.37 -10.49 7.87
Reported Net Profit 1,011.82 919.05 584.69 607.75 1,690.53 357.57
Extraordinary Items 60.45 53.61 -66.58 21.05 11.18 -117.79
Adjusted Net Profit 951.37 865.44 651.27 586.70 1,679.35 475.36
Adjustment below Net Profit 0.00 0.00 0.00 -17.08 -11.05 0.00
P & L Balance brought forward 1,044.37 870.71 828.12 1,745.02 562.71 882.77
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 711.51 745.39 542.10 1,524.66 508.22 677.62
P & L Balance carried down 1,344.68 1,044.37 870.71 811.03 1,733.98 562.71
Dividend 0.00 203.29 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 570.00 540.00 320.00 320.00 900.00 300.00
Dividend Per Share(Rs) 57.00 54.00 32.00 32.00 90.00 30.00
Earnings Per Share-Unit Curr 59.73 54.25 34.51 35.88 99.79 21.11
Earnings Per Share(Adj)-Unit Curr 59.73 54.25 34.51 35.88 99.79 21.11
Book Value 132.30 115.06 105.31 103.48 158.06 88.37
Book Value(Adj)-Unit Curr 132.30 115.06 105.31 103.48 158.06 88.37

Shareholding Pattern

  • Promoter Group

    75.00%

  • Public Share Holding

    25.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 127,054,524 75.00 127,054,524 4
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 94 0.00 94 2
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 18,048 0.01 11,084 18
Foreign Bank 111 0.00 111 1
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 8,044,401 4.75 8,044,401 241
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 3,935,853 2.32 3,935,853 16
Mutual Funds / UTI 10,286,404 6.07 10,279,964 36
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 125,660 0.07 112,776 17
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 22,410,571 13.23 22,384,283 331
2] Non Institution
Bodies Corporate 1,194,089 0.70 1,182,089 818
Clearing Members 353 0.00 353 3
Directors of their Relatives 600 0.00 600 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 883,130 0.52 876,764 4,130
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 365,258 0.22 365,258 2,217
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 331,615 0.20 331,615 11
Individuals holding nominal share capital up to Rs. 1 lakh 16,021,056 9.46 15,005,060 111,795
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 31,398 0.02 31,398 26
Others 1,113,440 0.66 1,113,440 1
Sub Total 19,940,939 11.77 18,906,577 119,002
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 169,406,034 100.00 168,345,384 119,337

Company Background

Glaxosmithkline Pharmaceuticals LtdPharmaceuticals - Multinational

  • Glaxosmithkline Pharmaceuticals Ltd
  • BSE Code : 195.0
  • ISIN : INE159A01016

  • Incorporation Year

    1924

  • Registered Office

    GSK House
    Dr Annie Besant Road Worli, Mumbai,
    Maharashtra-400030

  • Telephone

    91-022-24959595

  • FAX

    91-022-24959494

  • Chairman

    Renu S. Karnad

  • Managing Director

    Bhushan Akshikar

  • Company Secretary

    A A Nadkarni

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Glaxosmithkline Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Sanofi India 3,383.25 1,857.10 1,837.40 21.38 54.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77